arbekacin has been researched along with cilastatin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
| Arita, K; Kodama, T; Konishi, F; Kurimura, T; Kuwabara, M; Miyazawa, T; Miyoshi, N; Nakai, S; Santoh, T; Yokoyama, T | 1 |
| Hara, K; Hashimoto, A; Inoue, Y; Kaku, M; Koga, H; Kohno, S; Ohtsubo, T; Sugiyama, H; Taira, K; Tomono, K | 1 |
| Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J | 1 |
1 trial(s) available for arbekacin and cilastatin
| Article | Year |
|---|---|
[Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cilastatin; Dibekacin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1994 |
3 other study(ies) available for arbekacin and cilastatin
| Article | Year |
|---|---|
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cilastatin; Dibekacin; Female; Follow-Up Studies; Humans; Imipenem; Kidney; Male; Methicillin Resistance; Middle Aged; Minocycline; Recurrence; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |